Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction.
Petronio
A Sonia
AS
Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. as.petronio@gmail.com
De Carlo
Marco
M
Strata
Elisabetta
E
Gistri
Roberto
R
Palmieri
Cataldo
C
Aquaro
Giovanni
G
Borelli
Gabriele
G
Vaghetti
Marco
M
Delle Donne
MariaGrazia
M
Lombardi
Massimo
M
Berti
Sergio
S
D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000925:Anticoagulants / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004562:Electrocardiography; D004632:Emergency Medical Services / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D012720:Severity of Illness Index; D015996:Survival Rate; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab